Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Biotechnology

• Publication date

  2013-01-29

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1038/nbt.2507PMID 23360966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNA-Guided Human Genome Engineering via Cas9

  2013cited by this paper
• CRISPR-assisted editing of bacterial genomes

  2013cited by this paper
• Efficient In Vivo Genome Editing Using RNA-Guided Nucleases

  2013cited by this paper
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• Precision genome engineering with programmable DNA-nicking enzymes

  2012cited by this paper
• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

  2012cited by this paper
• FLASH Assembly of TALENs Enables High-Throughput Genome Editing

  2012cited by this paper
• Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases.

  2012cited by this paper
• RNA-guided genetic silencing systems in bacteria and archaea

  2012cited by this paper
• The emerging race to cure HIV infections.

  2011cited by this paper
• A TALE nuclease architecture for efficient genome editing

  2011cited by this paper
• A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity

  2011cited by this paper
• Surrogate reporters for enrichment of cells with nuclease-induced mutations

  2011cited by this paper
• Engineering a polarity-sensitive biosensor for time-lapse imaging of apoptotic processes and degeneration

  2010cited by this paper
• Targeted chromosomal deletions in human cells using zinc finger nucleases.

  2010cited by this paper
• Genome editing with modularly assembled zinc-finger nucleases

  2010cited by this paper
• Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly.

  2009cited by this paper
• Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

  2008cited by this paper

• DOTAP-Based Hybrid Nanostructured Lipid Carriers for CRISPR–Cas9 RNP Delivery Targeting TGFB1 in Diabetic Nephropathy

  2026cites this paper
• Abasic CRISPR RNAs inherently harness fidelity of SpCas9 for genome editing.

  2026cites this paper
• Potential of CRISPR/Cas9 Genome Engineering for Biofuel Production From Economically Relevant Algae

  2026cites this paper
• Next-generation gene therapy for infectious disease: Advances, challenges, and future directions.

  2026cites this paper
• Programmable genome editing in human cells using RNA-guided bridge recombinases.

  2026cites this paper
• The Chimeric Nuclease SpRYc Exhibits Highly Variable Performance Across Biological Systems

  2026cites this paper
• Evolution of Prime Editing: Enhancing Efficiency and Expanding Capacity.

  2026cites this paper
• Engineering delivery platforms for CRISPR-Cas and their applications in healthcare, agriculture and beyond

  2026cites this paper
• Clinical Trial Results Provide the Rationale to Protect Dual HIV-specific T Cells with a Signaling-Defective HIV Fusion Inhibitor.

  2026cites this paper
• Stage- and tissue-specific gene editing using 4-OHT–inducible Cas9 in whole organism

  2026cites this paper
• Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches

  2026cites this paper
• Miniaturized CRISPR: Ultra Compact Systems for In Vivo Delivery and Portable Diagnostics.

  2026cites this paper
• The functions of circular RNAs and long noncoding RNAs in cholangiocarcinoma

  2025cites this paper
• Revolutionizing CRISPR technology with artificial intelligence

  2025cites this paper
• A Guide to Guides: An Overview of SpCas9 sgRNA Scaffold Variants and Modifications

  2025cites this paper
• AI-generated MLH1 small binder improves prime editing efficiency.

  2025cites this paper
• Current Challenges With Highly Active Antiretroviral Therapy and New Hope and Horizon With CRISPR‐CAS9 Technology for HIV Treatment

  2025cites this paper
• Unlocking the potential: advancements and applications of gene therapy in severe disorders

  2025cites this paper
• Manipulation of floral senescence through gene editing: prospects for ornamental and cut flowers

  2025cites this paper
• Breaking Barriers to an HIV-1 Cure: Innovations in Gene Editing, Immune Modulation, and Reservoir Eradication

  2025cites this paper
• Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets.

  2025cites this paper
• Potential CRISPR-Cas9-based Antiviral Activity Against Hepatitis C Virus in Liver Cancer

  2025cites this paper
• CRISPR Technology and Its Emerging Applications

  2025cites this paper
• Assessing Microprocessor Complex Mutations with a Microsensor System.

  2025cites this paper
• Advanced gene editing techniques for enhancing disease resistance and climate resilience in crops.

  2025cites this paper
• CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability.

  2025cites this paper
• Cis- and trans-cleavage activity of CRISPR-Cas9 and its new developments in diagnostics

  2025cites this paper
• Selection of high yield recombinant human bone morphogenetic protein 2 (rhBMP2) cell pool based on different screening markers used for CHO cell line development

  2025cites this paper
• Applications of multiplexed CRISPR–Cas for genome engineering

  2025cites this paper
• Genetically modified chickens as bioreactors for protein-based drugs

  2025cites this paper
• Efficiency of genome editing using modified single-stranded oligodeoxyribonucleotides in human cells

  2025cites this paper
• CRISPR-Hybrid: A CRISPR-Mediated Intracellular Directed Evolution Platform for RNA Aptamers

  2025cites this paper
• CRISPR detection of cardiac tumor-associated microRNAs

  2025cites this paper
• Prime editing links the split integrated stress response to pathogenic eIF2B mutations and white matter degeneration

  2025cites this paper
• Generation and ophthalmological characterization of oculocutaneous albinism type 1 pig models by selection-free genome editing

  2025cites this paper
• CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

  2025cites this paper
• Precision rewriting of muscle genetics: therapeutic horizons of base and prime editing in skeletal muscle disorders.

  2025cites this paper
• Guarding the genome: strategies for off-target detection and minimization in CRISPR/Cas9 system

  2025cites this paper
• Engineering with care: safety assessment platforms for CRISPR-modified natural killer cells

  2025cites this paper
• Nature Inspired Delivery Vehicles for CRISPR-Based Genome Editing.

  2025cites this paper
• Improving the Efficiency and Safety of Human CCR5 Gene Editing by Selection of Optimal Guide RNAs for SpCAS9 and CAS12A

  2025cites this paper
• CRISPR/Cas9 System as a Promising Therapy in Thalassemia and Sickle Cell Disease: A Systematic Review of Clinical Trials

  2025cites this paper
• Gene Editing for Enhanced Swine Production: Current Advances and Prospects

  2025cites this paper
• Broadening the Nicotiana benthamiana research toolbox through the generation of dicer-like mutants using CRISPR/Cas9 approaches.

  2025cites this paper
• Leveraging CRISPR/Cas9 in notable bacteria for the production of industrially valuable compounds

  2025cites this paper
• Advancements in genome editing tools for genetic studies and crop improvement

  2025cites this paper
• High-fidelity CRISPR genome editing of single-nucleotide mutation with near-complementary guide RNA via enhanced target binding kinetics

  2025cites this paper
• Autophagy induction enhances homologous recombination-associated CRISPR–Cas9 gene editing

  2025cites this paper
• Therapeutic Applications of Genome Editing Tools for Genetic Diseases

  2025cites this paper
• Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells

  2025cites this paper
• In vivo delivery systems for CRISPR genome editing: Viral and non-viral carriers

  2025cites this paper
• Application of CRISPR/Cas gene editing for infectious disease control in poultry

  2025cites this paper
• New hope and promise with CRISPR-Cas9 technology for the treatment of HIV

  2025cites this paper
• Integrating genome editing with omics, artificial intelligence, and advanced farming technologies to increase crop productivity

  2025cites this paper
• Harnessing CRISPR/Cas9 to overcome targeted therapy resistance in non-small cell lung cancer: Advances and challenges (Review)

  2025cites this paper
• Off-target interactions in the CRISPR-Cas9 Machinery: mechanisms and outcomes

  2025cites this paper
• CRISPR/Cas9 genome engineering in PDAC: from preclinical studies to translation and clinical research.

  2025cites this paper
• RNA chemistry and therapeutics

  2025cites this paper
• Post-genomic era of CRISPR/Cas technology in ornamental plants: advantages, limitations, and prospects

  2025cites this paper
• Chemical Modifications in Nucleic Acid Therapeutics.

  2025cites this paper
• Efficient genetic perturbation of murine sensory neurons in vivo using CRISPR/Cas9

  2025cites this paper
• Revolutionizing forensic DNA analysis: The potential of CRISPR-Cas9 technology in genetic investigations.

  2025cites this paper
• Genome-edited peripheral blood stem cell-derived erythroid progenitor-4 cell line as the unique and beneficial panel cell for antibody identification

  2025cites this paper
• Enhanced production of sabinene by engineered Saccharomyces cerevisiae from corn hydrolysates

  2025cites this paper
• Deciphering acquired resistance mechanisms to sustained auxin-inducible protein degradation in cells and mice

  2025cites this paper
• CRISPR Delivery Systems for Organ-Specific Targeting: Advances and Challenges

  2025cites this paper
• Similarity-based transfer learning with deep learning networks for accurate CRISPR-Cas9 off-target prediction

  2025cites this paper
• Bacterial genome engineering using CRISPR-associated transposases

  2024cites this paper
• Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications

  2024cites this paper
• Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects.

  2024cites this paper
• Applications of CRISPR technologies to the development of gene and cell therapy

  2024cites this paper
• CRISPR/Cas9 as a Mutagenic Factor

  2024cites this paper
• The chemokine receptor CCR5: multi-faceted hook for HIV-1

  2024cites this paper
• Simplifying Genotyping of Mutants from Genome Editing with a Parallel qPCR-Based iGenotype Index

  2024cites this paper
• Large animal models for Huntington’s disease research

  2024cites this paper
• Donor template delivery by recombinant adeno-associated virus for the production of knock-in mice

  2024cites this paper
• CRISPR/Cas Technology in Disease Prevention and Control of Aquatic Animals

  2024cites this paper
• Efficient Genome Editing Using ‘NanoMEDIC’ AsCas12a-VLPs Produced with Pol II-Transcribed crRNA

  2024cites this paper
• Beyond precision: evaluation of off-target clustered regularly interspaced short palindromic repeats/Cas9-mediated genome editing.

  2024cites this paper
• Biology and applications of CRISPR–Cas12 and transposon-associated homologs

  2024cites this paper
• Postsynaptic competition between calcineurin and PKA regulates mammalian sleep–wake cycles

  2024cites this paper
• Advancements and challenges in CRISPR/cas genome editing for legume crops

  2024cites this paper
• Plant conservation in the age of genome editing: opportunities and challenges

  2024cites this paper
• Emerging Gene-editing nano-therapeutics for Cancer

  2024cites this paper
• Genome editing in Sub-Saharan Africa: a game-changing strategy for climate change mitigation and sustainable agriculture

  2024cites this paper
• Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles

  2024cites this paper
• Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

  2024cites this paper
• Making gene editing accessible in resource limited environments: recommendations to guide a first-time user

  2024cites this paper
• Advances in CRISPR/Cas systems-based cell and gene therapy.

  2024cites this paper
• CRISPR therapy: A revolutionary breakthrough in genetic medicine

  2024cites this paper
• High-Sensitivity Enzyme-Free Fluorescence Probe Based on CRISPR/Cas13 and the Isothermal Amplification Strategy for Axl Sensing.

  2024cites this paper
• Therapeutic Gene Editing in Dyslipidemias

  2024cites this paper
• Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

  2024cites this paper
• Scarless genome editing technology and its application to crop improvement

  2024cites this paper
• CRISPR-Cas technology in forensic investigations: Principles, applications, and ethical considerations.

  2024cites this paper
• Disease-modifying therapies for Alzheimer's disease: clinical trial progress and opportunity.

  2024cites this paper
• toward Practical Applications of Engineered Living Materials with Advanced Fabrication Techniques.

  2024cites this paper
• Editing Streptomyces genome using target AID system fused with UGI‐degradation tag

  2024cites this paper
• HepG2 PMM2-CDG knockout model: A versatile platform for variant and therapeutic evaluation.

  2024cites this paper
• Callus-specific CRISPR/Cas9 system to increase heritable gene mutations in maize

  2024cites this paper